Nexalin Technology, Inc. Increase (Decrease) in Deferred Revenue
Nexalin Technology, Inc. (NXL) reported Increase (Decrease) in Deferred Revenue of -$130.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2024-03-27
- Nexalin Technology, Inc. increase (decrease) in deferred revenue for the quarter ending 2022-12-31 was $0.00.
- Nexalin Technology, Inc. increase (decrease) in deferred revenue for the quarter ending 2022-09-30 was -$260.00K.
- Nexalin Technology, Inc. increase (decrease) in deferred revenue for the quarter ending 2022-06-30 was $78.00K.
- Nexalin Technology, Inc. increase (decrease) in deferred revenue for the quarter ending 2022-03-31 was $52.00K.
- Nexalin Technology, Inc. increase (decrease) in deferred revenue for fiscal 2022 was -$130.00K, a 200.00% decline from fiscal 2021.
- Nexalin Technology, Inc. increase (decrease) in deferred revenue for fiscal 2021 was $130.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$260.00K derived: sum of 2 quarters · filed 2024-03-27 | -$182.00K derived: sum of 3 quarters · filed 2024-03-27 | -$130.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | -$260.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$182.00K derived: sum of 2 quarters · filed 2023-11-13 | -$130.00K 10-Q · filed 2023-11-13 | -$130.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $130.00K 10-Q · filed 2023-08-10 | $130.00K derived: sum of 3 quarters · filed 2023-08-10 | |
| 2022-03-31 | $52.00K 10-Q · filed 2023-05-10 | $52.00K derived: sum of 2 quarters · filed 2023-05-10 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $130.00K 10-K · filed 2023-03-27 | ||
| 2021-09-30 | $130.00K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |